利妥昔单抗治疗富亮氨酸胶质瘤失活 1 蛋白抗体脑炎一例_West China Medical Journal

Authors：

李静雅 , 张婧 ,  王琳

Corresponding author：

王琳, Email: wanglinyiwan@126.com

Keywords：

富亮氨酸胶质瘤失活 1 蛋白抗体脑炎; 利妥昔单抗; 面臂肌张力障碍

DOI：

10.7507/1002-0179.202104271

Video：

Export PDF Favorites Scan Get Citation

Abstract Full text Figures/Tables Video References Cited by

Citation： 李静雅, 张婧, 王琳. 利妥昔单抗治疗富亮氨酸胶质瘤失活 1 蛋白抗体脑炎一例. West China Medical Journal, 2021, 36(6): 833-834. doi: 10.7507/1002-0179.202104271 Copy

1.	中华医学会神经病学分会. 中国自身免疫性脑炎诊治专家共识. 中华神经科杂志, 2017, 50(2): 91-98.
2.	van Sonderen A, Thijs RD, Coenders EC, et al. Anti-LGI1 encephalitis: clinical syndrome and long-term follow-up. Neurology, 2016, 87(14): 1449-1456.
3.	张婧, 赵文博, 武力勇. 富亮氨酸胶质瘤失活 1 蛋白 A 自身抗体相关边缘性脑炎 6 例临床分析. 中华实用诊断与治疗杂志, 2015, 29(10): 995-996.
4.	Shin YW, Lee ST, Shin JW, et al. VGKC-complex/LGI1-antibody encephalitis: clinical manifestations and response to immunotherapy. J Neuroimmunol, 2013, 265(1/2): 75-81.
5.	Markovic I, Basic S, Devedjija S. Aggressive anti-LGI1 encephalitis defeated by one cycle of intravenous rituximab-a case report. Neurol Sci, 2020, 41(7): 1949-1950.
6.	Brown JW, Martin PJ, Thorpe JW, et al. Long-term remission with rituximab in refractory leucine-rich glioma inactivated 1 antibody encephalitis. J Neuroimmunol, 2014, 271(1/2): 66-68.
7.	Bhandari B, Basyal B, Sendil S, et al. Atypical presentation of an elderly male with autoimmune encephalitis: anti-LG1 limbic encephalitis. J Community Hosp Intern Med Perspect, 2020, 10(4): 377-379.
8.	Nosadini M, Mohammad SS, Ramanathan S, et al. Immune therapy in autoimmune encephalitis: a systematic review. Expert Rev Neurother, 2015, 15(12): 1391-1419.

1. 中华医学会神经病学分会. 中国自身免疫性脑炎诊治专家共识. 中华神经科杂志, 2017, 50(2): 91-98.
2. van Sonderen A, Thijs RD, Coenders EC, et al. Anti-LGI1 encephalitis: clinical syndrome and long-term follow-up. Neurology, 2016, 87(14): 1449-1456.
3. 张婧, 赵文博, 武力勇. 富亮氨酸胶质瘤失活 1 蛋白 A 自身抗体相关边缘性脑炎 6 例临床分析. 中华实用诊断与治疗杂志, 2015, 29(10): 995-996.
4. Shin YW, Lee ST, Shin JW, et al. VGKC-complex/LGI1-antibody encephalitis: clinical manifestations and response to immunotherapy. J Neuroimmunol, 2013, 265(1/2): 75-81.
5. Markovic I, Basic S, Devedjija S. Aggressive anti-LGI1 encephalitis defeated by one cycle of intravenous rituximab-a case report. Neurol Sci, 2020, 41(7): 1949-1950.
6. Brown JW, Martin PJ, Thorpe JW, et al. Long-term remission with rituximab in refractory leucine-rich glioma inactivated 1 antibody encephalitis. J Neuroimmunol, 2014, 271(1/2): 66-68.
7. Bhandari B, Basyal B, Sendil S, et al. Atypical presentation of an elderly male with autoimmune encephalitis: anti-LG1 limbic encephalitis. J Community Hosp Intern Med Perspect, 2020, 10(4): 377-379.
8. Nosadini M, Mohammad SS, Ramanathan S, et al. Immune therapy in autoimmune encephalitis: a systematic review. Expert Rev Neurother, 2015, 15(12): 1391-1419.